ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and ...
09/30/2024. 2030 ambition to help more than 500 million people worldwide achieve their full health potential. Showcases integration of intelligent products and solutions within the ResMed ecosystem, designed to deliver a better experience, lower costs, and enhanced outcomes for patients and providers. Introduces updated five-year financial outlook.
ResMed Inc. CEO Executes Strategic Stock Transactions
1 day ago · Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh has released an update.ResMed Inc.’s CEO, Michael J. Farrell, has executed a series of stock transactions as part of a pre ...
News | Resmed Inc - ResMed Newsroom – ResMed news and …
Media Contact. [email protected]. 1.858.289.7272. Investor Contact. [email protected]. 1.858.836.5000. Newsroom Alerts. To opt-in for email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address.
UPDATE -- ResMed Unveils New Collection of Digital and …
SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD), the world’s leading health technology company focused on sleep, breathing, and care delivered in the home, today announced new patient-centric products designed to enhance the therapy journey for sleep apnea patients.
ResMed Adopts New Operating Model to Accelerate Long-term …
SAN DIEGO, November 9, 2023 – ResMed (NYSE: RMD, ASX: RMD) today announced a new operating model to accelerate long-term growth. The new operating model introduces dedicated leadership in Product, Revenue, and Marketing to the global executive team.
Press Releases :: ResMed Inc. (RMD)
Sep 30, 2024 · ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns Sep 30, 2024 9:48 am EDT UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
US FDA Identifies Recall of ResMed's Respiratory Devices as Most …
Jan 11, 2024 · (Reuters) - The U.S. Food and Drug Administration (FDA) on Thursday classified the recall of certain respiratory masks made by ResMed as most serious as their use could cause major injuries or...
ResMed Inc. Announces Results for the First Quarter of Fiscal Year …
SAN DIEGO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended September 30, 2024. First Quarter 2025 Highlights. All comparisons are to the prior year period. Revenue increased by 11% to $1.2 billion; up 11% on a constant currency basis.
ResMed Inc. Announces Results for the Second Quarter of Fiscal …
SAN DIEGO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended December 31, 2022. Second Quarter 2023 Highlights. All comparisons are...
FDA Issues New Recall Alert For ResMed CPAP Devices: Here's …
Jun 3, 2024 · On Jan. 12, the U.S. Food and Drug Administration classified the recall of some specific ResMed respiratory masks as Class 1, the most serious recall classification. “Use of these devices may cause serious injuries or death,” the FDA decided , typical of Class 1 classifications ( 1 ).